wt construct Search Results


90
GenScript corporation d 1 r-wt nm_000794
D 1 R Wt Nm 000794, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/plasmid+dna+constructs+and+aav+vectors+human+wild+type+d+1+r+wt+nm+000794+clone+id++ohu23409c/pmc07200283-155-0-34
Average 90 stars, based on 1 article reviews
d 1 r-wt nm_000794 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics biphasic ha/β-tcpof 4/96 (wt%) biomimetic calvarial constructs
Biphasic Ha/β Tcpof 4/96 (Wt%) Biomimetic Calvarial Constructs, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/biphasic+ha+%CE%B2+tcpof+4+96++wt+++biomimetic+calvarial+constructs/pmc03828877-30-7-6
Average 90 stars, based on 1 article reviews
biphasic ha/β-tcpof 4/96 (wt%) biomimetic calvarial constructs - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Promega luciferase reporter construct wt prgs22
Regulation of RGS22 expression by the binding of YY1 directly to the RGS22 promoter. (A-C) RGS22 expression in YY1-overexpressing PANC-1 cells or YY1-knockdown CFPAC-1 cells was measured by reverse transcription-quantitative PCR and western blotting. (D) Schematic diagram of the <t>luciferase</t> reporter construct containing the human RGS22 promoter and the mutant construct containing the RGS22 promoter in which the predicted YY1 binding site was mutated. (E) EMSA showing that YY1 binds to the RGS22 promoter. The wild-type probe was incubated without (lane 1) or with (lane 2) PANC-1-YY1 cell nuclear proteins in the absence or presence of unlabeled probes (lanes 3–6). Lanes 3 and 4 contain the wild-type probe, and lanes 5 and 6 contain the mutant probe, each at 50- and 100-fold molar excess. EMSA was performed using an anti-YY1 antibody (lane 7), and the IgG antibody was used as a negative control for the YY1 antibody (lane 8). (F) Luciferase assays demonstrated the luciferase activity of PANC-1 cells transfected with YY1-overexpression or control lentiviruses. Data are presented as the mean ± SD of three independent experiments.*P≤0.05, **P≤0.01, ***P≤0.001. EMSA, electrophoretic mobility shift assay; RGS22, Regulator of G-protein signaling 22; YY1, Yin Yang-1; OE, overexpression; NC, negative control; KD, knockdown; WT, wildtype; MT, mutant.
Luciferase Reporter Construct Wt Prgs22, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/luciferase+reporter+construct+wt+prgs22/pmc09650600-129-7-27
Average 90 stars, based on 1 article reviews
luciferase reporter construct wt prgs22 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
GenScript corporation rabbit polyclonal antibodies directed against ack13-hoxb13
Regulation of RGS22 expression by the binding of YY1 directly to the RGS22 promoter. (A-C) RGS22 expression in YY1-overexpressing PANC-1 cells or YY1-knockdown CFPAC-1 cells was measured by reverse transcription-quantitative PCR and western blotting. (D) Schematic diagram of the <t>luciferase</t> reporter construct containing the human RGS22 promoter and the mutant construct containing the RGS22 promoter in which the predicted YY1 binding site was mutated. (E) EMSA showing that YY1 binds to the RGS22 promoter. The wild-type probe was incubated without (lane 1) or with (lane 2) PANC-1-YY1 cell nuclear proteins in the absence or presence of unlabeled probes (lanes 3–6). Lanes 3 and 4 contain the wild-type probe, and lanes 5 and 6 contain the mutant probe, each at 50- and 100-fold molar excess. EMSA was performed using an anti-YY1 antibody (lane 7), and the IgG antibody was used as a negative control for the YY1 antibody (lane 8). (F) Luciferase assays demonstrated the luciferase activity of PANC-1 cells transfected with YY1-overexpression or control lentiviruses. Data are presented as the mean ± SD of three independent experiments.*P≤0.05, **P≤0.01, ***P≤0.001. EMSA, electrophoretic mobility shift assay; RGS22, Regulator of G-protein signaling 22; YY1, Yin Yang-1; OE, overexpression; NC, negative control; KD, knockdown; WT, wildtype; MT, mutant.
Rabbit Polyclonal Antibodies Directed Against Ack13 Hoxb13, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/hoxb13+wt+and+k13+acetylation+mutant+constructs+ha+tagged+or+gfp+tagged+full+length+hoxb13++hoxb13+k13a++hoxb13+k13r++and+hoxb13+g84e+constructs/10__1158_slash_1078___0432__ccr___21___3603-65-6-10
Average 90 stars, based on 1 article reviews
rabbit polyclonal antibodies directed against ack13-hoxb13 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare plasmid constructs the wild-type (wt) 246(pflag–neo–siglec-8l) construct containing full-length siglec-8
Regulation of RGS22 expression by the binding of YY1 directly to the RGS22 promoter. (A-C) RGS22 expression in YY1-overexpressing PANC-1 cells or YY1-knockdown CFPAC-1 cells was measured by reverse transcription-quantitative PCR and western blotting. (D) Schematic diagram of the <t>luciferase</t> reporter construct containing the human RGS22 promoter and the mutant construct containing the RGS22 promoter in which the predicted YY1 binding site was mutated. (E) EMSA showing that YY1 binds to the RGS22 promoter. The wild-type probe was incubated without (lane 1) or with (lane 2) PANC-1-YY1 cell nuclear proteins in the absence or presence of unlabeled probes (lanes 3–6). Lanes 3 and 4 contain the wild-type probe, and lanes 5 and 6 contain the mutant probe, each at 50- and 100-fold molar excess. EMSA was performed using an anti-YY1 antibody (lane 7), and the IgG antibody was used as a negative control for the YY1 antibody (lane 8). (F) Luciferase assays demonstrated the luciferase activity of PANC-1 cells transfected with YY1-overexpression or control lentiviruses. Data are presented as the mean ± SD of three independent experiments.*P≤0.05, **P≤0.01, ***P≤0.001. EMSA, electrophoretic mobility shift assay; RGS22, Regulator of G-protein signaling 22; YY1, Yin Yang-1; OE, overexpression; NC, negative control; KD, knockdown; WT, wildtype; MT, mutant.
Plasmid Constructs The Wild Type (Wt) 246(pflag–Neo–Siglec 8l) Construct Containing Full Length Siglec 8, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/plasmid+constructs+the+wild+type++wt++246+pflag+neo+siglec+8l++construct+containing+full+length+siglec+8/pmc02987348-109-9-18
Average 90 stars, based on 1 article reviews
plasmid constructs the wild-type (wt) 246(pflag–neo–siglec-8l) construct containing full-length siglec-8 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
GenScript corporation mouse construct of igfbp7 wt and mutants
Regulation of RGS22 expression by the binding of YY1 directly to the RGS22 promoter. (A-C) RGS22 expression in YY1-overexpressing PANC-1 cells or YY1-knockdown CFPAC-1 cells was measured by reverse transcription-quantitative PCR and western blotting. (D) Schematic diagram of the <t>luciferase</t> reporter construct containing the human RGS22 promoter and the mutant construct containing the RGS22 promoter in which the predicted YY1 binding site was mutated. (E) EMSA showing that YY1 binds to the RGS22 promoter. The wild-type probe was incubated without (lane 1) or with (lane 2) PANC-1-YY1 cell nuclear proteins in the absence or presence of unlabeled probes (lanes 3–6). Lanes 3 and 4 contain the wild-type probe, and lanes 5 and 6 contain the mutant probe, each at 50- and 100-fold molar excess. EMSA was performed using an anti-YY1 antibody (lane 7), and the IgG antibody was used as a negative control for the YY1 antibody (lane 8). (F) Luciferase assays demonstrated the luciferase activity of PANC-1 cells transfected with YY1-overexpression or control lentiviruses. Data are presented as the mean ± SD of three independent experiments.*P≤0.05, **P≤0.01, ***P≤0.001. EMSA, electrophoretic mobility shift assay; RGS22, Regulator of G-protein signaling 22; YY1, Yin Yang-1; OE, overexpression; NC, negative control; KD, knockdown; WT, wildtype; MT, mutant.
Mouse Construct Of Igfbp7 Wt And Mutants, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/mouse+construct+of+igfbp7+wt+and+mutants/pm38218180-211-12-13
Average 90 stars, based on 1 article reviews
mouse construct of igfbp7 wt and mutants - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
VectorBuilder GmbH third-generation lentiviral constructs plv for wt otulin
Regulation of RGS22 expression by the binding of YY1 directly to the RGS22 promoter. (A-C) RGS22 expression in YY1-overexpressing PANC-1 cells or YY1-knockdown CFPAC-1 cells was measured by reverse transcription-quantitative PCR and western blotting. (D) Schematic diagram of the <t>luciferase</t> reporter construct containing the human RGS22 promoter and the mutant construct containing the RGS22 promoter in which the predicted YY1 binding site was mutated. (E) EMSA showing that YY1 binds to the RGS22 promoter. The wild-type probe was incubated without (lane 1) or with (lane 2) PANC-1-YY1 cell nuclear proteins in the absence or presence of unlabeled probes (lanes 3–6). Lanes 3 and 4 contain the wild-type probe, and lanes 5 and 6 contain the mutant probe, each at 50- and 100-fold molar excess. EMSA was performed using an anti-YY1 antibody (lane 7), and the IgG antibody was used as a negative control for the YY1 antibody (lane 8). (F) Luciferase assays demonstrated the luciferase activity of PANC-1 cells transfected with YY1-overexpression or control lentiviruses. Data are presented as the mean ± SD of three independent experiments.*P≤0.05, **P≤0.01, ***P≤0.001. EMSA, electrophoretic mobility shift assay; RGS22, Regulator of G-protein signaling 22; YY1, Yin Yang-1; OE, overexpression; NC, negative control; KD, knockdown; WT, wildtype; MT, mutant.
Third Generation Lentiviral Constructs Plv For Wt Otulin, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/third+generation+lentiviral+constructs+plv+for+wt+otulin/pm38630025-346-15-17
Average 90 stars, based on 1 article reviews
third-generation lentiviral constructs plv for wt otulin - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
GenScript corporation wt and variant constructs containing the α1, β3 and γ2 subunits
Regulation of RGS22 expression by the binding of YY1 directly to the RGS22 promoter. (A-C) RGS22 expression in YY1-overexpressing PANC-1 cells or YY1-knockdown CFPAC-1 cells was measured by reverse transcription-quantitative PCR and western blotting. (D) Schematic diagram of the <t>luciferase</t> reporter construct containing the human RGS22 promoter and the mutant construct containing the RGS22 promoter in which the predicted YY1 binding site was mutated. (E) EMSA showing that YY1 binds to the RGS22 promoter. The wild-type probe was incubated without (lane 1) or with (lane 2) PANC-1-YY1 cell nuclear proteins in the absence or presence of unlabeled probes (lanes 3–6). Lanes 3 and 4 contain the wild-type probe, and lanes 5 and 6 contain the mutant probe, each at 50- and 100-fold molar excess. EMSA was performed using an anti-YY1 antibody (lane 7), and the IgG antibody was used as a negative control for the YY1 antibody (lane 8). (F) Luciferase assays demonstrated the luciferase activity of PANC-1 cells transfected with YY1-overexpression or control lentiviruses. Data are presented as the mean ± SD of three independent experiments.*P≤0.05, **P≤0.01, ***P≤0.001. EMSA, electrophoretic mobility shift assay; RGS22, Regulator of G-protein signaling 22; YY1, Yin Yang-1; OE, overexpression; NC, negative control; KD, knockdown; WT, wildtype; MT, mutant.
Wt And Variant Constructs Containing The α1, β3 And γ2 Subunits, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/wt+and+variant+constructs+containing+the+%CE%B11++%CE%B23+and+%CE%B32+subunits/pm37647766-53-9-17
Average 90 stars, based on 1 article reviews
wt and variant constructs containing the α1, β3 and γ2 subunits - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
GenScript corporation wt-wt heterodimer construct
Aminoacylation of homodimers . A , protein expression of compound heterozygosity of the subject, showing the 1:1:2 ratio of the homodimers F185L/F185L ( green ) and ΔE264/ΔE264 ( magenta ) to the <t>heterodimer</t> F185L-ΔE264. B , the nascent chain of an mt-TyrRS monomer of one ribosome can associate with the nascent chain of an adjacent ribosome on the same or a different mRNA to form a homodimer . C , Michaelis-Menten plots of the three homodimers WT/WT, F185L/F185L, and ΔE264/ΔE264, showing the r 2 of each. Error bars are shown for the WT/WT but are invisible for the two variants. D , kinetic parameters of each homodimer. Values are the average ± SD, N = 3 to 6.
Wt Wt Heterodimer Construct, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/wt+wt+heterodimer+construct/pmc11758952-126-1-7
Average 90 stars, based on 1 article reviews
wt-wt heterodimer construct - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
GenScript corporation 24-mer exon 7 peptide
Aminoacylation of homodimers . A , protein expression of compound heterozygosity of the subject, showing the 1:1:2 ratio of the homodimers F185L/F185L ( green ) and ΔE264/ΔE264 ( magenta ) to the <t>heterodimer</t> F185L-ΔE264. B , the nascent chain of an mt-TyrRS monomer of one ribosome can associate with the nascent chain of an adjacent ribosome on the same or a different mRNA to form a homodimer . C , Michaelis-Menten plots of the three homodimers WT/WT, F185L/F185L, and ΔE264/ΔE264, showing the r 2 of each. Error bars are shown for the WT/WT but are invisible for the two variants. D , kinetic parameters of each homodimer. Values are the average ± SD, N = 3 to 6.
24 Mer Exon 7 Peptide, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/three+minigenes+where+constructed+each+encompassing+exon+7+to+12+harboring+the+putative+splice+mutations+or+a+wild+type++wt++sequence/pmc02686187-49-12-22
Average 90 stars, based on 1 article reviews
24-mer exon 7 peptide - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
NZYTech Inc gfp-tagged n 1–419 wt construct
Aminoacylation of homodimers . A , protein expression of compound heterozygosity of the subject, showing the 1:1:2 ratio of the homodimers F185L/F185L ( green ) and ΔE264/ΔE264 ( magenta ) to the <t>heterodimer</t> F185L-ΔE264. B , the nascent chain of an mt-TyrRS monomer of one ribosome can associate with the nascent chain of an adjacent ribosome on the same or a different mRNA to form a homodimer . C , Michaelis-Menten plots of the three homodimers WT/WT, F185L/F185L, and ΔE264/ΔE264, showing the r 2 of each. Error bars are shown for the WT/WT but are invisible for the two variants. D , kinetic parameters of each homodimer. Values are the average ± SD, N = 3 to 6.
Gfp Tagged N 1–419 Wt Construct, supplied by NZYTech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/gfp+tagged+n+1+419+wt+construct/pm40503686-97-0-18
Average 90 stars, based on 1 article reviews
gfp-tagged n 1–419 wt construct - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Promega oecc luciferase reporter wild-type construct (oecc-wt
Aminoacylation of homodimers . A , protein expression of compound heterozygosity of the subject, showing the 1:1:2 ratio of the homodimers F185L/F185L ( green ) and ΔE264/ΔE264 ( magenta ) to the <t>heterodimer</t> F185L-ΔE264. B , the nascent chain of an mt-TyrRS monomer of one ribosome can associate with the nascent chain of an adjacent ribosome on the same or a different mRNA to form a homodimer . C , Michaelis-Menten plots of the three homodimers WT/WT, F185L/F185L, and ΔE264/ΔE264, showing the r 2 of each. Error bars are shown for the WT/WT but are invisible for the two variants. D , kinetic parameters of each homodimer. Values are the average ± SD, N = 3 to 6.
Oecc Luciferase Reporter Wild Type Construct (Oecc Wt, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wt+construct/oecc+luciferase+reporter+wild+type+construct++oecc+wt/pm30126634-91-0-19
Average 90 stars, based on 1 article reviews
oecc luciferase reporter wild-type construct (oecc-wt - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Regulation of RGS22 expression by the binding of YY1 directly to the RGS22 promoter. (A-C) RGS22 expression in YY1-overexpressing PANC-1 cells or YY1-knockdown CFPAC-1 cells was measured by reverse transcription-quantitative PCR and western blotting. (D) Schematic diagram of the luciferase reporter construct containing the human RGS22 promoter and the mutant construct containing the RGS22 promoter in which the predicted YY1 binding site was mutated. (E) EMSA showing that YY1 binds to the RGS22 promoter. The wild-type probe was incubated without (lane 1) or with (lane 2) PANC-1-YY1 cell nuclear proteins in the absence or presence of unlabeled probes (lanes 3–6). Lanes 3 and 4 contain the wild-type probe, and lanes 5 and 6 contain the mutant probe, each at 50- and 100-fold molar excess. EMSA was performed using an anti-YY1 antibody (lane 7), and the IgG antibody was used as a negative control for the YY1 antibody (lane 8). (F) Luciferase assays demonstrated the luciferase activity of PANC-1 cells transfected with YY1-overexpression or control lentiviruses. Data are presented as the mean ± SD of three independent experiments.*P≤0.05, **P≤0.01, ***P≤0.001. EMSA, electrophoretic mobility shift assay; RGS22, Regulator of G-protein signaling 22; YY1, Yin Yang-1; OE, overexpression; NC, negative control; KD, knockdown; WT, wildtype; MT, mutant.

Journal: Oncology Letters

Article Title: Suppressive effect of YY1-mediated RGS22 regulation on the proliferation, migration and invasion of pancreatic ductal adenocarcinoma

doi: 10.3892/ol.2022.13577

Figure Lengend Snippet: Regulation of RGS22 expression by the binding of YY1 directly to the RGS22 promoter. (A-C) RGS22 expression in YY1-overexpressing PANC-1 cells or YY1-knockdown CFPAC-1 cells was measured by reverse transcription-quantitative PCR and western blotting. (D) Schematic diagram of the luciferase reporter construct containing the human RGS22 promoter and the mutant construct containing the RGS22 promoter in which the predicted YY1 binding site was mutated. (E) EMSA showing that YY1 binds to the RGS22 promoter. The wild-type probe was incubated without (lane 1) or with (lane 2) PANC-1-YY1 cell nuclear proteins in the absence or presence of unlabeled probes (lanes 3–6). Lanes 3 and 4 contain the wild-type probe, and lanes 5 and 6 contain the mutant probe, each at 50- and 100-fold molar excess. EMSA was performed using an anti-YY1 antibody (lane 7), and the IgG antibody was used as a negative control for the YY1 antibody (lane 8). (F) Luciferase assays demonstrated the luciferase activity of PANC-1 cells transfected with YY1-overexpression or control lentiviruses. Data are presented as the mean ± SD of three independent experiments.*P≤0.05, **P≤0.01, ***P≤0.001. EMSA, electrophoretic mobility shift assay; RGS22, Regulator of G-protein signaling 22; YY1, Yin Yang-1; OE, overexpression; NC, negative control; KD, knockdown; WT, wildtype; MT, mutant.

Article Snippet: Each transfection was performed using 1 μg luciferase reporter construct (WT pRGS22 or MT pRGS22) plus 2.5 ng Renilla luciferase reporter vector, pRL-SV40 as an internal control (Promega Corporation).

Techniques: Expressing, Binding Assay, Knockdown, Reverse Transcription, Real-time Polymerase Chain Reaction, Western Blot, Luciferase, Construct, Mutagenesis, Incubation, Negative Control, Activity Assay, Transfection, Over Expression, Control, Electrophoretic Mobility Shift Assay

Aminoacylation of homodimers . A , protein expression of compound heterozygosity of the subject, showing the 1:1:2 ratio of the homodimers F185L/F185L ( green ) and ΔE264/ΔE264 ( magenta ) to the heterodimer F185L-ΔE264. B , the nascent chain of an mt-TyrRS monomer of one ribosome can associate with the nascent chain of an adjacent ribosome on the same or a different mRNA to form a homodimer . C , Michaelis-Menten plots of the three homodimers WT/WT, F185L/F185L, and ΔE264/ΔE264, showing the r 2 of each. Error bars are shown for the WT/WT but are invisible for the two variants. D , kinetic parameters of each homodimer. Values are the average ± SD, N = 3 to 6.

Journal: The Journal of Biological Chemistry

Article Title: A kinetic model for compound heterozygous pathogenic variants in Tyrosyl-tRNA synthetase gene YARS2 -Associated neonatal phenotype

doi: 10.1016/j.jbc.2024.108092

Figure Lengend Snippet: Aminoacylation of homodimers . A , protein expression of compound heterozygosity of the subject, showing the 1:1:2 ratio of the homodimers F185L/F185L ( green ) and ΔE264/ΔE264 ( magenta ) to the heterodimer F185L-ΔE264. B , the nascent chain of an mt-TyrRS monomer of one ribosome can associate with the nascent chain of an adjacent ribosome on the same or a different mRNA to form a homodimer . C , Michaelis-Menten plots of the three homodimers WT/WT, F185L/F185L, and ΔE264/ΔE264, showing the r 2 of each. Error bars are shown for the WT/WT but are invisible for the two variants. D , kinetic parameters of each homodimer. Values are the average ± SD, N = 3 to 6.

Article Snippet: The WT-WT heterodimer construct was made by GenScript, where the native YARS2 was covalently linked to a recoded gene and the cassette was cloned into the BamHI and EcoRV sites of pET30a.

Techniques: Expressing

Aminoacylation of heterodimers. A , assembly of a heterodimer via a covalent link of two monomers as translated by a ribosome based on one copy of YARS2 in the native sequence ( green ), followed by the linker ( cyan ), and the recoded sequence ( magenta ). B , Michaelis-Menten plots of WT-WT and F185L-ΔE264, showing the r 2 of each. C , kinetic parameters of each homodimer vs. heterodimer, showing the fold-decrease in k cat / K m relative to WT/WT. Individual values are the average ± SD (N = 4–6). D , Western blot of an SDS-PAGE of homo- and heterodimers, where the markers were superimposed from the image of a pre-stained gel. E , Western blot of a native PAGE of unlinked and linked proteins, marking the YARS2 protein by an arrow, which was recognized by the α-His antibody (as shown) and the α-mt-TyrRS antibody (not shown). The lower band was recognized only by the α-His antibody, indicating that it is a co-purified contaminant. The different migration profile of F185L/F185L could be due to perturbation of the dimer interface when F185L was in an unlinked homodimer. F , Western blot analysis of limited trypsin digestion of WT/WT, WT-WT, and F185L-ΔE264, showing degradation products in red boxes .

Journal: The Journal of Biological Chemistry

Article Title: A kinetic model for compound heterozygous pathogenic variants in Tyrosyl-tRNA synthetase gene YARS2 -Associated neonatal phenotype

doi: 10.1016/j.jbc.2024.108092

Figure Lengend Snippet: Aminoacylation of heterodimers. A , assembly of a heterodimer via a covalent link of two monomers as translated by a ribosome based on one copy of YARS2 in the native sequence ( green ), followed by the linker ( cyan ), and the recoded sequence ( magenta ). B , Michaelis-Menten plots of WT-WT and F185L-ΔE264, showing the r 2 of each. C , kinetic parameters of each homodimer vs. heterodimer, showing the fold-decrease in k cat / K m relative to WT/WT. Individual values are the average ± SD (N = 4–6). D , Western blot of an SDS-PAGE of homo- and heterodimers, where the markers were superimposed from the image of a pre-stained gel. E , Western blot of a native PAGE of unlinked and linked proteins, marking the YARS2 protein by an arrow, which was recognized by the α-His antibody (as shown) and the α-mt-TyrRS antibody (not shown). The lower band was recognized only by the α-His antibody, indicating that it is a co-purified contaminant. The different migration profile of F185L/F185L could be due to perturbation of the dimer interface when F185L was in an unlinked homodimer. F , Western blot analysis of limited trypsin digestion of WT/WT, WT-WT, and F185L-ΔE264, showing degradation products in red boxes .

Article Snippet: The WT-WT heterodimer construct was made by GenScript, where the native YARS2 was covalently linked to a recoded gene and the cassette was cloned into the BamHI and EcoRV sites of pET30a.

Techniques: Sequencing, Western Blot, SDS Page, Staining, Clear Native PAGE, Purification, Migration